Worldwide Blood Glucose Monitoring Market Research Report — Global Forecast till 2023 Size, Growth, Emerging Technologies, Demand, Competitive, Regional Landscape with Global Forecast To 2023
Global continuous glucose monitoring market players is expected to grow at a CAGR of 7.1% during the forecast period 2017–2023.
Leading Market Players
Some of key the players in the market are Abbott Laboratories (U.S.), Arkay, Inc. (U.S.), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Goldsite Diagnostics Inc., GlySure Ltd (U.K), Sphere Medical Holding plc. (U.K), Dexcom, Inc. (U.S.), and LifeScan, Inc. (U.S.).
Market Overview
Blood Glucose Monitoring can be defined as the process of testing the diabetes level in the blood. The devices help to identify the blood glucose level within the specific target range. The monitoring devices help to track the progression of treatment and observe the effects of medication on blood sugar level. The surging prevalence of diabetes is likely to favour the market growth in the coming years.
The blood glucose monitoring market is considered one of the rapidly expanding markets, mainly due to the surging growth in urbanization, leading to soaring incidences of obesity. Developments in technology, increased investment in R&D activities, and surging awareness regarding these devices are some of the primary growth stimulants of the market.
Segmental Analysis
By mode of product type, continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others.
By mode of application, type 1 diabetes, type 2 diabetes, and others.Type-I and type-II diabetes are further sub-segmented into pediatrics and adult. The rising prevalence of type-II diabetes is fueling the growth of the use of blood glucose monitoring system.
By mode of end-users, hospitals, diagnostic centers, research centers, clinics,and home care diagnostics. Among these, the homecare segment is considered to dominate the global market owing to an increased diabetic population coupled with the growing preference for minimally invasive technologies which can be used at home.
Intended Audience
- Blood Glucose Monitoring Devices Suppliers
- Blood Glucose Monitoring Devices Manufacturers
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Academic Medical Institutes and Universities
- Hospitals and Clinics
- Homecare Diagnostics
Industry Updates
January 03, 2019: A team of researchers at KTH Royal Institute of Technology, Stockholm have recently developed a promising alternativefor people with diabetes. A microneedle patch with 50 times smaller than the needles used in the CGM systems, this glucose monitor is a reliable and comfortable blood-sugar monitoring system which has proven to be virtually painless and more accurate.
Regional Insights
The American region is estimated to command the largest market share and is likely to maintain its pole position in the coming years. The growth has been ascribed to the surging incidences of obesity, physical inactivity, and unhealthy diet. As per the D, in 2015 the incidences of diagnosed as well as undiagnosed diabetes population were 30.3 million of the total US population
The European region is likely to occupy the second spot in the global market due to environmental pollutants, sociological deprivation, and psychological factors
The Asia Pacific region is estimated to expand at the fastest rate due to surging geriatric population, changing lifestyle, and urbanization. The rapidly developing healthcare technology, increasing expenditure on healthcare, high concentration of prominent companies, and surging R&D activities are some of the top factors likely to offer the market a boom. The surging demand for new treatment technologies especially in the economies like South Korea and India is further estimated to contribute to the market growth. As per the International diabetes federation, there were approximately 69.1 million suffering from diabetes.
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/blood-glucose-monitoring-market-557
Table of Content
- Report Prologue
- Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
- Research End Userology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
- Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Continued…..
Browse other healthcare-related reports
population health management industry report
Home Healthcare Market Information
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market ScenarioThe Global Blood Glucose Monitoring Market is predicted to register 10.7% CAGR during the forecast period (2017-2023) owing to the increased diabetic population across the globe, asserts Market Research Future (MRFR).
Blood Glucose Monitoring is referred to as the process of testing diabetes level in the blood which helps to identify the glucose level in the blood within a specific target range.Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4921The various blood glucose monitoring devices available in the market are termed as blood glucose meter.
These devices offer useful insights to manage diabetes and helps in tracking the progress of treatment goal.
Moreover, physical inactiveness and unhealthy diet has further contributed to the market growth.Increasing awareness of diabetes, development of new technologies, and rising investment in research and development activities have fueled the market growth during the appraisal period.
Huge surge in the geriatric population and rising product launch and approvals are further influencing the market growth.On the flip side, high cost associated with the monitoring and diagnosis of diseases is one of the major concerns considered to impede the market growth in the coming years.Moreover, product recalls coupled with inadequate reimbursements are some of the factors presumed to dampen the market growth to an extent.Global Blood Glucose Monitoring Market: Segmental AnalysisThe Global Blood Glucose Monitoring Market has been segmented on the basis of application, product type, end-user, and region.By mode of product type, the global blood glucose monitoring market has been segmented into continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others.By mode of application, the global blood glucose monitoring market has been segmented intotype 1 diabetes, type 2 diabetes, and others.Type-I and type-II diabetes are further sub-segmented into pediatrics and adult.
The rising prevalence of type-II diabetes is fueling the growth of the use of blood glucose monitoring system.By mode of end-users, the global blood glucose monitoring market has been segmented intohospitals, diagnostic centers, research centers, clinics,and home care diagnostics.
To avoid further complications, regular monitoring of the glucose level is required.As per the International Diabetes Federation, the number of diabetic population is estimated to touch 642 million by the end of 2040 across the globe.
Therefore, one out of every ten adult is estimated to suffer from diabetes by 2040.
The management and treatment of diabetes is likely to be the prime focus area of the healthcare stakeholders and department.
The surging incidences of diabetes will offer the market huge growth opportunities which will compel and attract market players to develop product line extensions.On the contrary, the high cost of diagnosis and monitoring of the diseases is considered as a top factor vitiating the market growth across the globe.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/557 Global Blood Glucose Monitoring Market: Segmental AnalysisThe Global Blood Glucose Monitoring Market has been segmented on the basis of application, product type, and end user.By mode of product type, the global blood glucose monitoring market has been segmented into continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others.
Among these, the type 2 diabetes is likely to command the major share in the global market due to the rising prevalence of type 2 diabetes and growing innovative product launches with less invasive techniques.By mode of end users, the global blood glucose monitoring market has been segmented into hospitals, diagnostic centers, research centers, clinics, and home care diagnostics.
Among these, the home care diagnostics is likely to gain prominence owing to the surging diabetic population, rising awareness regarding regular monitoring of the glucose levels, and growing product launches which enhances the patient comfort at home.Regional InsightsGeographically, the blood glucose monitoring market span across regions namely, Asia Pacific, America, Europe, and the Middle East & Africa.Considering the global scenario, the American region is estimated to command the largest market share and is likely to maintain its pole position in the coming years.
This report presents the worldwide Smart Wearable Fitness Devices Sensors market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.The Smart Wearable Fitness Devices Sensors market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period.
In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Smart Wearable Fitness Devices Sensors.Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/2317753The following manufacturers are covered in this report:HoneywellAbbott LaboratoriesMedtronicOmronAcute TechnologyHoffmann-La RocheJohnson & JohnsonGE HealthcareAdidasAnalog DevicesBayerFujitsuPhilipsQualcommBoschLifeScanSmart Wearable Fitness Devices Sensors Breakdown Data by TypeTemperature SensorPressure SensorSpeed SensorGas SensorOtherBrowse the complete report @ http://www.orbisresearch.com/reports/index/global-smart-wearable-fitness-devices-sensors-market-insights-forecast-to-2025Smart Wearable Fitness Devices Sensors Breakdown Data by ApplicationChildrenAdultsThe ElderlySmart Wearable Fitness Devices Sensors Production by RegionUnited StatesEuropeChinaJapanSouth KoreaOther RegionsThe study objectives are:To analyze and research the global Smart Wearable Fitness Devices Sensors status and future forecast involving, production, revenue, consumption, historical and forecast.To present the key Smart Wearable Fitness Devices Sensors manufacturers, production, revenue, market share, and recent development.To split the breakdown data by regions, type, manufacturers and applications.To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.To identify significant trends, drivers, influence factors in global and regions.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.This report includes the estimation of market size for value (million USD) and volume (K Units).
Both top-down and bottom-up approaches have been used to estimate and validate the market size of Smart Wearable Fitness Devices Sensors market, to estimate the size of various other dependent submarkets in the overall market.
Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research.
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.For the data information by region, company, type and application, 2017 is considered as the base year.
Whenever data information was unavailable for the base year, the prior year has been considered.Place a purchase order of this report @ http://www.orbisresearch.com/contact/purchase/2317753About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
The global U.S. Advanced Wound Care Market report offers a comprehensive assessment of the market for the forecast years.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2020-2027.The leading companies in the Global U.S. Advanced Wound Care Market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile, and STD Reimbursement Scenario Analysis And Top Study Testing Technologies products and services.The key market players for the global U.S. Advanced Wound Care Market are listed below:ABBOTT LABORATORIESBIOTRONIK SE & CO. KGBOSTON SCIENTIFIC CORPORATIONGENERAL ELECTRIC COMPANY (GE HEALTHCARE)F. HOFFMANN-LA ROCHE LTD.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)MASIMO CORPORATIONMEDTRONIC PLC.NIHON KOHDEN CORPORATIONOSI Systems, Inc. (Spacelabs Healthcare)(A PDF | Sample Of The Report Is Available Immediately Upon Request) @ https://www.alliedmarketresearch.com/request-sample/7003 The Global U.S. Advanced Wound Care Market Report is equipped with market data from 2020 to 2027.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.Covid-19 Scenario:1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.Detailed COVID-19 Impact Analysis on Market: https://www.alliedmarketresearch.com/request-for-customization/7003?reqfor=covid Why Purchase this Report?A robust research methodology has been followed to collect data for the report.
Data, thus collected passes through multiple quality checks to ensure the best quality is served.The report gives a holistic view of the competitive scenario of the U.S. Advanced Wound Care Market.The latest product launches along with technological changes and development are covered in the report.The data analysis in the report helps in understanding the anticipated U.S. Advanced Wound Care Market dynamics from 2020 to 2027.Decision Databases has a vast repository of data, therefore, we can accommodate customized requirements also.The graphs, tables and pie charts, and info-graphics covered in the report will help in a better understanding of the report.The market drivers, restraints, upcoming opportunities, and anticipated restraints cited in the report will assist in making an informed decision.Interested in Procuring this Report?
Visit Here: https://www.alliedmarketresearch.com/purchase-enquiry/7003 About Us:Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon.
The Cystic Fibrosis Therapeutics Market Report, in its latest update, highlights the significant impacts and the recent strategical changes under the present socio-economic scenario.
The Cystic Fibrosis Therapeutics industry growth avenues are deeply supported by exhaustive research by the top analysts of the industry.
The report starts with the executive summary, followed by a value chain and marketing channels study.
The report then estimates the CAGR and market revenue of the global and regional segments.Base Year: 2020Estimated Year: 2021Forecast Till: 2027The report classifies the market into different segments based on type and product.
The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.Get | Download FREE Sample Report of Global Cystic Fibrosis Therapeutics Market @ https://www.decisiondatabases.com/contact/download-sample-7837A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Cystic Fibrosis Therapeutics market.
The impact is closely studied in terms of production, import, export, and supply.The report covers the complete competitive landscape of the Worldwide Cystic Fibrosis Therapeutics market with company profiles of key players such as:Abbott LaboratoriesActavis GenericsAnthera PharmaceuticalsArcturus TherapeuticsBoehringer IngelheimChiesi Farmaceutici SpAF.
It helps Type 1 and Type 2 diabetes patients to manage blood test results from a glucose meter, records of actual insulin delivery, statistical evaluation.
The increasing prevalence of diabetes, technological advancements, rising demand for selfcare, and involvement of major players in product launch, collaboration, and strategic merger & acquisitions are the major factors driving the growth of the global digital diabetes management market.
Additionally, increasing research and development spending by the top players are fueling the growth of the market during forecast period.
The European market is expected to be the second-largest due to government funding and support of the healthcare sector, coupled with increasing research and development.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing investments in healthcare, rising number of the diabetes patient, expansions strategy by market players in the region, and favorable government initiatives for healthcare facilities.
SegmentationThe global digital diabetes management market has been segmented on the basis of type, product and services, end user, and region.On the basis of type, the market has been classified as wearable devices and handheld devices.
